Tikosyn and Methylprednisolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tikosyn (dofetilide) and Methylprednisolone (methylprednisolone). Common drug interactions include heart rate increased among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Tikosyn and Methylprednisolone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Tikosyn?

Tikosyn has active ingredients of dofetilide. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 12,202 Tikosyn users. Check the latest studies of Tikosyn.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.



On Aug, 08, 2026

23 people who take Tikosyn and Methylprednisolone together, and have interactions are studied.

Tikosyn and Methylprednisolone drug interactions.

What are the common drug interactions of Tikosyn and Methylprednisolone, by gender? *:

female:

  1. Heart rate increased
  2. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  3. Abdominal pain upper
  4. Anaemia (lack of blood)
  5. Blood potassium increased
  6. Dizziness
  7. Hot flush (sudden feelings of heat)
  8. Injury
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Pain in jaw

male:

  1. Cardiac failure congestive
  2. Back pain
  3. Fatigue (feeling of tiredness)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Multiple injuries
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Abdominal pain
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Partner stress
  10. Renal cell carcinoma (a kidney cancer)

What are the common drug interactions of Tikosyn and Methylprednisolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood pressure increased
  2. Headache (pain in head)
  3. Pain
  4. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  5. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  6. Anxiety
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Arthralgia (joint pain)
  9. Blood glucose increased
  10. Blood pressure decreased

50-59:

  1. Hallucination, visual (seeing things that aren't there)
  2. Headache (pain in head)
  3. Herpes zoster
  4. Hot flush (sudden feelings of heat)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Swelling
  7. Abnormal behaviour
  8. Agitation (state of anxiety or nervous excitement)
  9. Asthma
  10. Atrial tachycardia (rhythm disturbance that arises in the atria)

60+:

  1. Pain
  2. Cardiac failure congestive
  3. Multiple injuries
  4. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  5. Emotional disorder
  6. Fatigue (feeling of tiredness)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Abdominal pain
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Atrial Tachycardia (rhythm disturbance that arises in the atria): 7 people, 30.43%
  2. Cardiac Failure Congestive: 4 people, 17.39%
  3. Cardiac Disorder: 4 people, 17.39%
  4. Nausea (feeling of having an urge to vomit): 2 people, 8.70%
  5. Multiple Myeloma (cancer of the plasma cells): 2 people, 8.70%
  6. Indigestion: 2 people, 8.70%
  7. Ill-Defined Disorder: 2 people, 8.70%
  8. Hypersensitivity: 2 people, 8.70%
  9. Arrhythmias (irregular heartbeat): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tikosyn and Methylprednisolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tikosyn and Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tikosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tikosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylprednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dofetilide and methylprednisolone (the active ingredients of Tikosyn and Methylprednisolone, respectively), and Tikosyn and Methylprednisolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: